<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-30T03:59:47Z</responseDate><request verb="GetRecord" identifier="oai:bayburt-rdlopen.rawdatalibrary.net:bayburt/13795" metadataPrefix="oai_dc">https://bayburt-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:bayburt-rdlopen.rawdatalibrary.net:bayburt/13795</identifier><datestamp>2026-10-29T19:52:18Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_bayburt_10000</setSpec><setSpec>col_bayburt_10001</setSpec><setSpec>com_bayburt_10007</setSpec><setSpec>col_bayburt_10218</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Impact of antibacterial drugs on human serum paraoxonase-1 (hPON1) activity: An in vitro study</dc:title><dc:creator>Söyüt, Hakan</dc:creator><dc:creator>Kaya, Elif Duygu</dc:creator><dc:creator>Beydemir, Şükrü</dc:creator><dc:subject>Cefoperazone sodium</dc:subject><dc:subject>Inhibition</dc:subject><dc:subject>Meropenem trihydrate</dc:subject><dc:subject>Paraoxonase</dc:subject><dc:subject>Piperacillin sodium</dc:subject><dc:description>Objective: To investigate the in vitro effects of the antibacterial drugs, meropenem trihydrate, piperacillin sodium, and cefoperazone sodium, on the activity of human serum paraoxonase (hPON1). Methods: hPON1 was purified from human serum using simple chromatographic methods, including DEAE-Sephadex anion exchange and Sephadex G-200 gel filtration chromatography. Results: The three antibacterial drugs decreased in vitro hPON1 activity. Inhibition mechanisms meropenem trihydrate was noncompetitive while piperacillin sodium and cefoperazone sodium were competitive. Conclusions: Our results showed that antibacterial drugs significantly inhibit hPON1 activity, both in vitro, with rank order meropenem trihydrate piperacillin sodium cefoperazone sodium in vitro.</dc:description><dc:publisher>Asian Pacific Tropical Biomedicine Press</dc:publisher><dc:date>2014</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/bayburt/13795</dc:identifier><dc:identifier>https://doi.org/10.12980/apjtb.4.2014apjtb-2014-0059</dc:identifier><dc:identifier>2221-1691</dc:identifier><dc:language>en</dc:language><dc:relation>Asian Pacific Journal of Tropical Biomedicine</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://bayburt-rdlopen.rawdatalibrary.net/tr/items/bayburt/13795</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>